Photo taken from Aman Chauhan/X
Sep 11, 2023, 18:28
Aman Chauhan: Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!
Quoting Aman Chauhan, Leader of the Sylvester Comprehensive Cancer Center’s Neuroendocrine Tumor Program, on Twitter:
“Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!! We are now even more excited for Paltusotine Carcinoid study. Please checkout our Trials in Progress Poster from ENETS.”
For details click here.
Source: Aman Chauhan/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 15:20
Nov 18, 2024, 14:45
Nov 18, 2024, 12:57
Nov 18, 2024, 12:54
Nov 18, 2024, 12:50